Exicure (XCUR) Share-based Compensation (2016 - 2025)
Exicure (XCUR) reported Share-based Compensation of $1000.0 for Q4 2025, down 83.33% on a YoY basis from $6000.0 in Q4 2024, and little changed quarter-over-quarter from $1000.0 in Q2 2025.
Exicure (XCUR) Share-based Compensation (2016 - 2025) Analysis & Trends
Exicure has reported Share-based Compensation for 10 years, with the latest figure at $1000.0 in Q4 2025.
- For the quarter ending Q4 2025, Share-based Compensation fell 83.33% year-over-year to $1000.0; the trailing twelve-month figure through Dec 2025 stood at $2000.0 (down 90.91% YoY), and the FY2025 full-year result was $2000.0, down 90.91% from the prior year.
- Share-based Compensation for Q4 2025 stood at $1000.0, roughly flat from $1000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $969000.0 in Q2 2023, with the low at $1000.0 in Q2 2025.
- Historically, Share-based Compensation has averaged $315555.6 across 5 years, with a median of $260000.0 in 2022.
- Annual changes were most pronounced in 2023 — Share-based Compensation jumped 91.12% — and 2024, when it slumped 99.38%.
- Exicure's Share-based Compensation stood at $769000.0 in 2021, then sank by 70.35% to $228000.0 in 2022, then tumbled by 90.79% to $21000.0 in 2023, then sank by 71.43% to $6000.0 in 2024, then plunged by 83.33% to $1000.0 in 2025.
- The last three Share-based Compensation figures came in at $1000.0 (Q4 2025), $1000.0 (Q2 2025), and $6000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 305,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 26.47 Mn |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 969,000.00 |
| Jun 30, 2023 | 969,000.00 |
| Mar 31, 2023 | 308,000.00 |
| Mar 31, 2023 | 308,000.00 |